Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 801–900 of 1,001
Ouyang, W., Ma, Q., Li, J., Zhang, D., Ding, J., Huang, Y., Xing, M., & Huang, C. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20260 · Cited by 36
“Our previous study revealed that all three members of MAPKs, including ERKs, p38K, and JNKs, are involved in the AP-1 activation by B[a]PDE [42].”
BackgroundInfluentialChen, L.-W., Lin, M.-W., & Hsu, C.-M. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-1704-1 · Cited by 42
“p38 is activated by cellular stress, including hyperosmotic shock [ 7 ], heat shock [8], ultraviolet irradiation [9], endotoxin [10], certain cytokines (TNF-a and IL-1) and G-protein-coupled receptors (GPCR) [7].”
BackgroundOkuno, T., Matsuoka, M., Sumizawa, T., & Igisu, H. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0022-8 · Cited by 36
“In mammalian systems, three major members of MAP-Ks, a family of Ser/Thr protein kinases, have been identified; extracellular signal-regulated protein kinase (ERK), p38, and c-Jun NH2-terminal kinase (Seger and Krebs 1995; Treisman 1996; Whitmarsh and Davis 1996 ).”
BackgroundMolecular ‘palpation’ of BPH: a tale of MAPK signalling?
Papatsoris, A., & Papavassiliou, A. G. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02015-9 · Cited by 38
Weber, H. C., Walters, J., Leyton, J., Casibang, M., Purdom, S., Jensen, R. T., Coy, D. H., Ellis, C. A., Clark, G., & Moody, T. W. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00941-9 · Cited by 35
VIP-ellipticine derivatives inhibit the growth of breast cancer cells
Moody, T. W., Czerwinski, G., Tarasova, N. I., & Michejda, C. J. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01741-1 · Cited by 35
Souza, R. F., Shewmake, K., Shen, Y., Ramirez, R. D., Bullock, J. S., Hladik, C. L., Lee, E. L., Terada, L. S., & Spechler, S. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41122.x · Cited by 35
“The mitogen activated protein kinase (MAPK) pathways transmit extracellular, growth-regulating signals to effector genes in the nucleus (6).”
BackgroundJeon, Y., Jung, Y., Kim, M. C., Kwon, H. C., Kang, K. S., Kim, Y. K., & Kim, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.026 · Cited by 36
Lesch, A., Hui, X., Lipp, P., & Thiel, G. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.095695 · Cited by 34
“AP-1 activity is regulated by MAP kinases in different cell types (Karin, 1995; Whitmarsh and Davis, 1996).”
BackgroundTanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway
Wang, H., Zhong, L., Mi, S., Song, N., Zhang, W., & Zhong, M. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01289-z · Cited by 36
“Phosphorylation of JNK2 is the end-stage of the pathway; however, inhibition of the MKK/JNK pathway may induce unexpected complications because the activation of the MKK/JNK signal pathway regulates a range of biological processes and occurs inside platelets [20, 21].”
BackgroundHwang, Y. P., Choi, J. H., Kim, H. G., Choi, J. M., Hwang, S. K., Chung, Y. C., & Jeong, H. G. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.04.005 · Cited by 39
“AP-1 complexes consist of Jun and Fos family members [33].”
BackgroundVerma, N. K., Dempsey, E., Long, A., Davies, A. M., Barry, S. P., Fallon, P. G., Volkov, Y., & Kelleher, D. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376616 · Cited by 34
“Cell-permeable AG490, STAT3-specific inhibitor peptide, and JNK inhibitor II SP600125 were fromMerck Millipore.”
BackgroundInfluentialFu, Y., Zhang, H., Ding, M., Li, Y., Fu, X., Yu, Z., & Meadows, G. G. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20766 · Cited by 38
“The phosphorylation on Ser338 and Tyr441 of Raf is required for its activation (Whitmarsh and Davis, 1996; Rommel et al., 1999; Zang et al., 2002).”
BackgroundTian, H., Gao, Z., Wang, G., Li, H., & Zheng, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4370-6 · Cited by 37
GCKR Links the Bcr-Abl Oncogene and Ras to the Stress-Activated Protein Kinase Pathway
Shi, C.-S., Tuscano, J. M., Witte, O. N., & Kehrl, J. H. (1999) · Blood · doi:10.1182/blood.v93.4.1338 · Cited by 34
Shimizu, Y., Kinoshita, I., Kikuchi, J., Yamazaki, K., Nishimura, M., Birrer, M. J., & Dosaka‐Akita, H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604267 · Cited by 37
“Many extracellular stimuli rapidly activate and induce cJun through cytoplasmic signalling cascades to activate cJun target gene transcription (Karin, 1996; Liu et al, 1996; Whitmarsh and Davis, 1996).”
BackgroundKim, H.-H., Chung, W. J., Lee, S. W., Chung, P.-J., You, J. W., Kwon, H. J., Tanaka, S., & Lee, Z. H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00288-x · Cited by 37
Medin, C. L., & Rothman, A. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/502630 · Cited by 34
“kinase (JNK), in addition to p38 [35].”
Role of the ATFa/JNK2 complex in Jun activation
Graeve, F. D., Bahr, A., Sabapathy, K., Hauss, C., Wagner, E. F., Kédinger, C., & Chatton, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202723 · Cited by 36
“The JNKs were initially identi®ed by their ability to bind the N-terminus of the c-Jun protein, on a site (now de®ned as the docking site) encompassing amino acids 33 ± 47, and to subsequently phosphorylate the Ser63 and Ser73 residues (Whitmarsh and Davis, 1996; Minden and Karin, 1997).”
BackgroundPalcy, S., Bolivar, I., & Goltzman, D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2352 · Cited by 34
“Overall, the cfos promoter is complex, and a variety of response elements have been identified, (17) indicating that several signaling path ways can lead to cfos gene transcription.”
BackgroundFernandez, P. C., Machado, J., Heussler, V. T., Botteron, C., Palmer, G. H., & Dobbelaere, D. A. E. (1999) · Biological Chemistry · doi:10.1515/bc.1999.178 · Cited by 34
“The JNK and p38 pathways have been reported to regulate the phosphorylation and activation of transcription factors such as AP-1 and ATF-2 (Gupta et al., 1995) (reviewed in Whitmarsh and Davis, 1996).”
BackgroundNegi, A., Ramarao, P., & Kumar, R. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313050004 · Cited by 33
Investigating the potential of Shikonin as a novel hypertrophic scar treatment
Fan, C., Xie, Y., Dong, Y., Su, Y., & Upton, Z. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0172-9 · Cited by 35
Tumor-suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494
Wang, Y., Xu, J., Gao, G., Li, J., Huang, H., Jin, H., Zhu, J., Che, X., & Huang, C. (2015) · Oncogene · doi:10.1038/onc.2015.470 · Cited by 36
Early responses of human periodontal ligament fibroblasts to cyclic and static mechanical stretching
Papadopoulou, A., Iliadi, A., Eliades, T., & Kletsas, D. (2016) · European Journal of Orthodontics · doi:10.1093/ejo/cjw075 · Cited by 33
“AP-1 is a homodimeric/heterodimeric complex consisted of members of the Fos and Jun families of transcription factors, controlling gene expression by binding to specific motifs in the regulatory regions of target genes (13).”
BackgroundAn insight into crosstalk among multiple signaling pathways contributing to epileptogenesis
Gautam, V., Rawat, K., Sandhu, A., Kumari, P., Singh, N., & Saha, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174469 · Cited by 34
Chen, J., Chen, Y., Lin, C., Fong, Y., Hsu, C., Tsai, C., Su, J.-L., & Tang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3397 · Cited by 34
Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells
Leyton, J., Garcı́a, L. J., Jensen, R. T., & Moody, T. W. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01539-x · Cited by 33
Poljakovic, M., Nygren, J., & Persson, K. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01716-3 · Cited by 33
Gandhi, A. S., Guo, T., Shah, P., Moorthy, B., & Ghose, R. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.030 · Cited by 37
Zhao, Y., & Chen, L. H. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.09.003 · Cited by 38
“Lipopolysaccharide stimulation activates JNK, which phosphorylates the transcriptional activation domain of cJun and greatly enhances the trans-activating potential of cJun [16–18].”
BackgroundInfluentialWang, X., Hu, S., Mao‐Ying, Q., Li, Q., Yang, C.-J., Zhang, H., Mi, W., Wu, G.-C., & Wang, Y. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-21 · Cited by 33
“JNK activation is mediated by the dual phosphorylation on Thr and Tyr by two MAPK kinases (MKK4/7), and several transcriptional factors can be regulated by JNK activation [5].”
BackgroundEupatilin with PPARα agonistic effects inhibits TNFα-induced MMP signaling in HaCaT cells
Jung, Y., Kim, J., Choi, Y.-S., Lee, S., Kang, K. S., Kim, Y. K., & Kim, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.043 · Cited by 34
Virucidal, antiviral and immunomodulatory activities of β-escin and Aesculus hippocastanum extract
Michelini, F. M., Alché, L. E., & Bueno, C. A. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13002 · Cited by 33
“In fact, previously it was reported that b-escin inhibits the activation of P38 and ERK in endothelial cells, and one nuclear target of these MAP kinase signalling pathways is the transcription factor AP-1.”
BackgroundERK mediates inhibition of Na+/H+exchange and HCO 3 − absorption by nerve growth factor in MTAL
Watts, B. A., & Good, D. W. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00133.2001 · Cited by 33
“Mitogen-activated protein (MAP) kinases are essential intermediates in signaling pathways activated by multiple stimuli, including growth factors, hormones, neurotransmitters, cytokines, and environmental stress (32, 43).”
BackgroundInfluentialvan Riggelen, J., Buchwalter, G., Soto, U., Arce, J. D.-C., Hausen, H. Z., Wasylyk, B., & Rösl, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409915200 · Cited by 41
“Only ERK1/2 showed constitutive phosphorylation in non-tumorigenic hybrids (“444”), arguing for a stronger functionality of the upstream kinases MEK1 and 2 (56).”
Background[13] Mitogen-activated protein kinase activation by singlet oxygen and ultraviolet A
Klotz, L., Briviba, K., & Sies, H. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)19015-9 · Cited by 33
Butterfield, L., Zentrich, E., Beekman, A. M., & Heasley, L. E. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380681 · Cited by 33
Effects of HIV-1 Nef on Cellular Gene Expression Profiles
Shaheduzzaman, S., Krishnan, V., Petrovic, A., Bittner, M. L., Meltzer, P. S., Trent, J. M., Venkatesan, S., & Zeichner, S. L. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256581 · Cited by 37
microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review
Clark, R. J., Craig, M. P., Agrawal, S., & Kadakia, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24145 · Cited by 35
“Of note, increased MAPK signaling through JNK and p38 is believed to contribute to the intestinalization in BE through induction of activated AP-1, a transcription complex that includes JUN and FOS heterodimers [72].”
BackgroundNorris, P. S., & Ware, C. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_13 · Cited by 39
Han, E. H., Park, J. H., Kang, K. W., Jeong, T. C., Kim, H. S., & Jeong, H. G. (2009) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390903212873 · Cited by 35
“MAPK are serine/threonine protein kinases that control various cellular processes, including cell growth, proliferation, differentiation, and apoptosis (Whitmarsh & Davis, 1996).”
BackgroundDefining boundaries during joint cavity formation: going out on a limb
Lamb, K. J., Lewthwaite, J. C., Bastow, E. R., & Pitsillides, A. A. (2003) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2003.00338.x · Cited by 33
“Major targets of these MAPK signalling pathways are the transcription factors, activator protein-1 (AP-1) (Whitmarsh & Davis 1996) and Elk (Yang et al. 1998).”
BackgroundMitogen‐activated protein kinase pathway mediates DBP–maf‐induced apoptosis in RAW 264.7 macrophages
Gumireddy, K., Reddy, C. D., & Swamy, N. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10615 · Cited by 39
Choi, Y. H., Lee, S., Aoyagi, H., Yamasaki, Y., Yoo, J., Park, B., Shin, D. M., Yoon, H., & Yoon, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247684 · Cited by 32
Expression and Distribution of AP-1 Transcription Factors in the Porcine Ovary1
Rusovici, R., & LaVoie, H. A. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.013995 · Cited by 32
“Although there are few reports directly linking ovarian hormonal and growth factor mechanisms to AP-1 factors, signaling pathways such as protein kinase A (PKA), protein kinase C (PKC), and mitogen-activated protein (MAP) kinases have been shown to utilize AP-1 factors as downstream effectors in other systems [2, 20].”
BackgroundLi, T., Wadsworth, S. A., Mercer, J. C., Mueller, C., Kirsten, L. Y. N. N., Siekierka, J. J., & August, A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630175 · Cited by 33
Macrophage Stimulating Protein
Leonard, E. J., & Danilkovitch, A. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60786-1 · Cited by 32
Chuang, S., & Yang, J. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1017967408266 · Cited by 32
“Usually, activation of the JNK and p38 pathways is involved in growth arrest and apoptosis [2, 3], whereas the ERK cascade is an important pathway for mitogenesis and differentiation [1, 6].”
BackgroundYang, J., New, L., Jiang, Y., Han, J., & Su, B. (1998) · Gene · doi:10.1016/s0378-1119(98)00158-9 · Cited by 38
Schmitt, A. B., Breuer, S., Voell, M., Schwaiger, F., Spitzer, C., Pech, K., Brook, G. A., Noth, J., Kreutzberg, G. W., & Nacimiento, W. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0231 · Cited by 32
Yang, R., Yu, W., Lu, L., Cui, Z., Tang, J., Li, G., Jin, M., Gu, Y., & Lu, E. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.031 · Cited by 38
“The SRE-Luc reporter and AP-1-Luc reporter systems were then used to detect ERK1/2 and JNK activation [26,27].”
Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells
Wang, H., Jiang, Y., Wei, X., Huang, H., Tashiro, S., Onodera, S., & Ikejima, T. (2009) · Free Radical Research · doi:10.3109/10715760903300717 · Cited by 32
Asur, R. S., Balasubramaniam, M., Marples, B., Thomas, R. A., & Tucker, J. D. (2010) · Mutagenesis · doi:10.1093/mutage/geq003 · Cited by 37
“Sustained activation and nuclear accumulation of the MAPK proteins are required for changes in expression and stabilization of the targets (57,95).”
BackgroundHwang, Y. P., Kim, H. G., Han, E. H., Choi, J. H., Park, B. H., Jung, K. H., Shin, Y. C., & Jeong, H. G. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.04.008 · Cited by 31
Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state
Matsumoto, T., Kinoshita, T., Matsuzaka, H., Nakai, R., Kirii, Y., YOKOTA, K., & Tada, T. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs023 · Cited by 37
Plößl, K., Weber, B. H. F., & Friedrich, U. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13019 · Cited by 34
Spicer, Z., & Millhorn, D. E. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:277 · Cited by 34
“Conversely, mitogenic and differentiative stimuli activate the Erk pathways in a Rasdependent manner [51,52].”
BackgroundThe molecular basis of O2-sensing and hypoxia tolerance in pheochromocytoma cells
Conrad, P., Conforti, L., Kobayashi, S., Beitner‐Johnson, D., Rust, R. T., Yuan, Y., Kim, H., Kim, R. H., Seta, K. A., & Millhorn, D. E. (2001) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(00)00326-2 · Cited by 32
Son, Y., Kook, S., Choi, K., Jang, Y., Choi, Y.-S., Jeon, Y., Kim, J., Hwang, H., & Lee, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.003 · Cited by 31
Waetzig, G. H., & Schreiber, S. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01642.x · Cited by 36
Hayakawa, K., Meng, Y., Hiramatsu, N., Kasai, A., Yamauchi, K., Yao, J. Q., & Kitamura, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2529 · Cited by 31
“Expression of c-jun is also regulated by c-Jun and ATF-2 that are phosphorylated by JNK and/or p38 MAPK (19).”
BackgroundDownstream factors in transforming growth factor-β family signaling
Visser, J. A., & Themmen, A. P. N. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00198-1 · Cited by 35
SREBP‐1: Gene Regulatory Key to Syndrome X?
Müller‐Wieland, D., & Kotzka, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04259.x · Cited by 32
Fatima, S., Khandekar, Z., Parmentier, J. H., & Malik, K. U. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29385-x · Cited by 31
Kočan, M., Sarwar, M., Hossain, M. A., Wade, J. D., & Summers, R. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12623 · Cited by 30
“Our study directly examined MAPKs that contribute to the AP-1 reporter response including p38MAPK (Roux and Blenis, 2004), JNK (Davis, 2000) and ERK (Price et al., 1996; Whitmarsh and Davis, 1996).”
BackgroundCD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
Griesing, S., Liao, B.-C., & Yang, J. C. (2021) · Anticancer Research · doi:10.21873/anticanres.14880 · Cited by 32
Lee, E.-R., Kim, J., Choi, H. Y., Jeon, K., & Cho, S. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000329973 · Cited by 34
Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells
Cazillis, M., Bringuier, A. F., Delautier, D., Buisine, M., Bernuau, D., Gespach, C. P., & Groyer, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207619 · Cited by 34
“MAPK and SAPK regulate a variety of developmental processes and are involved in cellular responses to environmental cues (Marshall, 1995; Su and Karin, 1996; Treisman, 1996; Whitmarsh and Davis, 1996).”
BackgroundRamos‐Niño, M. E., Haegens, A., Shukla, A., & Mossman, B. T. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015924413043 · Cited by 34
“Like the JNK subgroup, p38 can be activated by environmental stresses, cytokines, and/or endotoxins including bacterial lipopolysaccharide [14, 18].”
BackgroundDhandapani, K. M., Khan, M. M., Wade, F. M., Wakade, C. G., Mahesh, V. B., & Brann, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21182 · Cited by 33
MUKHOPADHYAY, S., MUKHERJEE, S., Smith, M. E., & Das, S. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.07.005 · Cited by 30
“MAPK signaling pathways have been shown to affect AP-1 ctivity by direct phosphorylation of AP-1 proteins and by influnce on the abundance of individual AP-1 components in a cell Karin, 1995; Whitmarsh and Davis, 1996).”
BackgroundAndrogen inhibition of MAP kinase pathway and Elk-1 activation in proliferating osteoblasts
Wiren, K. M., Toombs, A. R., & Zhang, X. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320209 · Cited by 33
“…reflection of both the levels and/or the phosphorylation of Fos, increased by MAP kinase activation through all three MAP kinase cascades and by protein kinase C activation, and of Jun, which is also sensitive to MAP kinase activation predominantly through the JNK pathway (Whitmarsh & Davis 1996).”
BackgroundBratton, M. R., Frigo, D. E., Vigh‐Conrad, K. A., Fan, D., Wadsworth, S., McLachlan, J. A., & Burow, M. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn213 · Cited by 29
“protein (CREB)-binding protein] class of general coactivators to their N- and C-terminal activation domains, respectively [ 1 ,2].”
BackgroundFernandes, N., Bailey, D. E., Vranken, D. L. V., & Allbritton, N. L. (2007) · ACS Chemical Biology · doi:10.1021/cb700158q · Cited by 37
Ramos‐Niño, M. E., Haegens, A., Shukla, A., & Mossman, B. T. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1087-1_12 · Cited by 29
Chambers, M., Kirkpatrick, G., Evans, M., Górski, G. K., Foster, S., & Borghaei, R. C. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.010 · Cited by 33
“formation of dimers with Jun proteins [46].”
Kang, K. A., Zhang, R., Piao, M. J., Ko, D. O., Wang, Z. H., Lee, K., Kim, B., Shin, T., Park, J. W., Lee, N. H., et al. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/01932690801934653 · Cited by 29
“The activation of the transcriptional factor AP-1 is subsequently regulated by the ERK protein ( Whitmarsh & Davis, 1996 ).”
BackgroundFuture Target Molecules in Antiglaucoma Therapy: TGF-β May Have a Role to Play
Agarwal, R., & Agarwal, P. (2009) · Ophthalmic Research · doi:10.1159/000246571 · Cited by 29
“A major nuclear target for MAPK signaling pathways is the transcription factor AP-1 (activator protein 1) [”
BackgroundChandru, H., & Boggaram, V. (2006) · Gene · doi:10.1016/j.gene.2006.12.011 · Cited by 29
“It is known that p38, p44/p42 and JNK MAPKs regulate AP-1 activity (Whitmarsh and Davis, 1996).”
BackgroundDendritic Cells and Contact Dermatitis
Sasaki, Y., & Aiba, S. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0034-7 · Cited by 33
“Activated MAPKs then phosphorylate their respective substrates on serine or threonine residues [43–45].”
BackgroundZhang, W., Chuang, Y., Jin, T., Swanson, R., Xiong, Y., Leung, L. L. K., & Olson, S. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4449 · Cited by 30
“25), fibroblast growth factor-20 (26), signal transducer and activator of transcription (STAT) family proteins 2, 3, and 6 (27), and MAP kinase 3 (28).”
Mackiewicz, U., Ma̧czewski, M., Konior, A., Tellez, J. O., Nowis, D., Dobrzynski, H., Boyett, M. R., & Lewartowski, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn285 · Cited by 34
Luff, S. A., & Papoutsakis, E. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707174 · Cited by 34
“The enriched GO cluster for JNK regulation (Table 1F) complements the up-regulation ofAP-1 transcripts (Table 1D), whose expression can be directly induced by JNK (65).”
BackgroundHyperforin activates gene transcription involving transient receptor potential C6 channels
Thiel, G., & Rößler, O. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.007 · Cited by 29
Malagoli, D., Gobba, F., & Ottaviani, E. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00531-7 · Cited by 29
Ihara, E., Hirano, K., Hirano, M., Nishimura, J., Nawata, H., & Kanaide, H. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10295 · Cited by 29
Role of Platelets and Serine Proteinases in Coupling of Blood Coagulation and Inflammation
Strukova, S. M. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000046880.91848.01 · Cited by 29
Matesanz, N., Lafuente, N., Azcutia, V., Martín, D., Cuadrado, A., Nevado, J., Rodríguez‐Mañas, L., Sánchez‐Ferrer, C. F., & Peiró, C. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328013e7c4 · Cited by 34
Shi, X., Siggins, R. W., Stanford, W. L., Melvan, J. N., Basson, M. D., & Zhang, P. (2013) · Infection and Immunity · doi:10.1128/iai.01280-12 · Cited by 32
“The AP-1 family is composed of members of the Jun and Fos subfamilies, which belong to the basic leucine zipper domain (bZIP) group of DNA binding proteins (32).”
BackgroundRole of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide.
Aklilu, F., Gladu, J., Goltzman, D., & Rabbani, S. A. (2000) · PubMed · Cited by 29
UV‐A‐induced AP‐1 activation requires the Raf/ERK pathway in human NCTC 2544 keratinocytes
Djavaheri‐Mergny, M., & Dubertret, L. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.010003204.x · Cited by 29
Efects of growth hormone and cadmium on the transcription regulation of two metallothionein isoforms
Vergani, L., Lanza, C., Borghi, C., Scarabelli, L., Panfoli, I., Burlando, B., Dondero, F., Viarengo, A., & Gallo, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.08.010 · Cited by 29
VPAC1Receptors and Lung Cancer
Moody, T. W., Walters, J. L., Casibang, M., Zia, F. Z., & Gozes, Y. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06947.x · Cited by 29
Cooperative effects of rhinovirus and TNF-α on airway epithelial cell chemokine expression
Newcomb, D. C., Sajjan, U. S., Nagarkar, D. R., Goldsmith, A. M., Bentley, J. K., & Hershenson, M. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00060.2007 · Cited by 29
Yasuda, T., Shimizu, M., Nakagawa, T., Julovi, S. M., & Nakamura, T. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000056999.08437.b2 · Cited by 29
“Activation of MAPK families ERK, p38, and JNK results in the production of phosphorylated active AP-1 transcription factor (Eder, 1997; Whitmarsh and Davis, 1996).”
BackgroundAsplin, I. R., Misra, U. K., Gawdi, G., Gonzalez–Gronow, M., & Pizzo, S. V. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2052 · Cited by 29
Bálint, D., Póti, Á. L., Alexa, A., Sok, P., Albert, K., Torda, L., Földesi-Nagy, D., Csókás, D., Turczel, G., Imre, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52573-2 · Cited by 30
Inflammation and Immune Pathways in Myopia: An Overview on Pathomechanisms and Treatment Prospects
Zhang, J., Kamoi, K., Zong, Y., Yang, M., Zou, Y., & Ohno‐Matsui, K. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09094-7 · Cited by 32
“AP-1 is a dimeric transcription factor consisting of Jun and Fos family proteins that can be activated through the mitogen-activated protein kinase (MAPK) pathway, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK [90].”
Chen, Y.-J., Shie, M., Hung, C.-J., Wu, B., Liu, S.-L., Huang, T., & Kao, C. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0549-3 · Cited by 32
“Several studies have shown that FAKs are downstream mechanosensors of integrins as well as upstream effectors that promote ERK1/2 phosphorylation in cells under stress loading [10, 27].”
Background
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.